Retrospective study of radiologically confirmed hospital-acquired venous thromboembolic disease

被引:2
|
作者
Carrim, ZI
Ruckley, CV
Boyd, J
Sutherland, M
Murchison, JT
机构
[1] Univ Edinburgh, Royal Infirm Edinburgh, Dept Surg, Edinburgh EH3 9YW, Midlothian, Scotland
[2] Royal Infirm Edinburgh NHS Trust, Dept Clin Effectiveness, Edinburgh, Midlothian, Scotland
[3] Royal Infirm Edinburgh NHS Trust, Dept Clin Radiol, Edinburgh, Midlothian, Scotland
关键词
venous thromboembolism; prophylaxis; pulmonary embolism; deep vein thrombosis;
D O I
10.1258/026835505774964919
中图分类号
R61 [外科手术学];
学科分类号
摘要
Objective: To study hospital-acquired venous thromboembolic disease (HAVTED) and the relationship between its incidence and compliance with thromboprophylaxis protocols. Methods: For the past eight years, specialty-specific protocols for VTE prophylaxis have been in operation throughout this hospital. Patients developing radiologically proven VTE either as inpatients or within 12 weeks of discharge were identified from a register. Patients were categorized according to risk as per the Scottish Intercollegiate Guidelines Network (SIGN) guidelines. The use of pharmacological prophylaxis for VTE was recorded. Results: Over a period of 24 months, 98 patients had radiologically proven HAVTED. Of 44 categorized as high risk, 17 (39%) had received prophylaxis. Corresponding figures for 50 at medium risk and four at low risk were 16 (32%) and three (75%), respectively. The overall incidence of HAVTED averaged two per 1000 inpatient discharges varying between 0.2 in General Medicine and 6.6 in Trauma Orthopaedics. The mean additional cost of treating a case of HAVTED was estimated at 3,000. pound Conclusion: Audit of radiological investigations of VTE showed that 18% of all cases were hospital acquired. A hospital policy of thromboprophylaxis may reduce but does not eliminate HAVTED. A substantial proportion of patients with HAVTED had not received prophylaxis. The possibility of a further reduction in incidence of HAVTED with potential saving in morbidity, mortality and cost is highlighted. The implementation and efficacy of thromboprophylaxis protocols should be monitored.
引用
收藏
页码:196 / 199
页数:4
相关论文
共 50 条
  • [31] Timing of Hospital-acquired Venous Thromboembolism and Its Relationship with Venous Thromboembolism Prevention Measures in Immobile Patients
    Hao Pham
    Russell, Todd
    Seiwert, Andrew
    Kasper, Gregory
    Lurie, Fedor
    ANNALS OF VASCULAR SURGERY, 2019, 56 : 24 - 28
  • [32] Management of venous thromboembolic disease in ambulatory and hospital,settings:: an assessment of general practices in France
    Bénard, E
    Priollet, P
    Delecroix, M
    JOURNAL DES MALADIES VASCULAIRES, 2004, 29 (03) : 139 - 144
  • [33] Predictive Ability of the Braden QD Scale for Hospital-Acquired Venous Thromboembolism in Hospitalized Children
    Gonzalez, Andrea Banuet
    Mulet, Yessica Martinez
    Song, Nancy
    Loh, Ling
    Scheinker, David
    Shin, Andrew Y.
    Donnelly, Lane F.
    JOINT COMMISSION JOURNAL ON QUALITY AND PATIENT SAFETY, 2022, 48 (10) : 513 - 520
  • [34] Periodontal disease as a risk factor of recurrence of venous thromboembolic disease: a prospective study
    Sanchez-Siles, Mariano
    Rosa-Salazar, Vladimir
    Salazar-Sanchez, Noemi
    Camacho-Alonso, Fabio
    ACTA ODONTOLOGICA SCANDINAVICA, 2015, 73 (01) : 8 - 13
  • [35] Venous Thromboembolic Complications to Hysterectomy for Benign Disease: A Nationwide Cohort Study
    Kahr, Henriette Strom
    Thorlacius-Ussing, Ole
    Christiansen, Ole Bjarne
    Skals, Regitze Kuhr
    Torp-Pedersen, Christian
    Knudsen, Aage
    JOURNAL OF MINIMALLY INVASIVE GYNECOLOGY, 2018, 25 (04) : 715 - +
  • [36] The Effect of Antipsychotic Treatment on Recurrent Venous Thromboembolic Disease: A Cohort Study
    Ferraris, Augusto
    Szmulewicz, Alejandro G.
    Lourdes Posadas-Martinez, M.
    Serena, Marina Alonso
    Vazquez, Fernando J.
    Angriman, Federico
    JOURNAL OF CLINICAL PSYCHIATRY, 2019, 80 (05)
  • [37] Trends of Hospital-Acquired Lower Extremity Deep Venous Thrombosis in an Academic Medical Center in China from 2007 to 2021
    Wang, Xiao
    Wang, Jing
    Zhang, Xiaoming
    Zhang, Xuemin
    Li, Qingle
    Li, Wei
    Jiang, Jingjun
    Jiao, Yang
    Zhang, Tao
    ANNALS OF VASCULAR SURGERY, 2025, 115 : 3 - 12
  • [38] 'Black Box' to 'Conversational' Machine Learning: Ondansetron Reduces Risk of Hospital-Acquired Venous Thromboembolism
    Datta, Arghya
    Matlock, Matthew K.
    Dang, Na Le
    Moulin, Thiago
    Woeltje, Keith F.
    Yanik, Elizabeth L.
    Swamidass, Sanjay Joshua
    IEEE JOURNAL OF BIOMEDICAL AND HEALTH INFORMATICS, 2021, 25 (06) : 2204 - 2214
  • [39] Comparative Performance of Clinical Risk Assessment Models for Hospital-Acquired Venous Thromboembolism in Medical Patients
    Blondon, Marc
    Spirk, David
    Kucher, Nils
    Aujesky, Drahomir
    Hayoz, Daniel
    Beer, Jurg H.
    Husmann, Marc
    Frauchiger, Beat
    Korte, Wolfgang
    Wuillemin, Walter A.
    Bounameaux, Henri
    Righini, Marc
    Nendaz, Mathieu
    THROMBOSIS AND HAEMOSTASIS, 2018, 118 (01) : 82 - 89
  • [40] Patients' perceptions and experiences of the prevention of hospital-acquired thrombosis: a qualitative study
    Apenteng, Patricia N.
    Fitzmaurice, David
    Litchfield, Ian
    Harrison, Sian
    Heneghan, Carl
    Ward, Alison
    Greenfield, Sheila
    BMJ OPEN, 2016, 6 (12):